Quick Answer
Camp4 Therapeutics Corp reported Shares Outstanding of 51.90 million shares for fiscal year 2025.
Camp4 Therapeutics Corp Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 51.90M | +157.6% |
| 2024 | 20.15M | +4272.7% |
| 2023 | 460,704 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 46.88M | +4560.4% | +132.5% |
| June 30, 2025 | 20.16M | — | +0.0% |
| March 31, 2025 | 20.16M | — | +0.1% |
| December 31, 2024 | 20.15M | +4272.7% | +1902.6% |
| September 30, 2024 | 1.01M | — | +118.3% |
| December 31, 2023 | 460,704 | — | — |
- Camp4 Therapeutics Corp showed an increase of +157.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2025 period, Camp4 Therapeutics Corp’s shares outstanding has grown by 11165.9% (from 460.7 thousand shares to 51.90 million shares).
- The most recent figure is from Camp4 Therapeutics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: